Edition:
United States

Profile: Abcam PLC (ABCA.L)

ABCA.L on London Stock Exchange

1,394.00GBp
11:35am EDT
Change (% chg)

-13.00 (-0.92%)
Prev Close
1,407.00
Open
1,415.00
Day's High
1,420.00
Day's Low
1,385.00
Volume
577,382
Avg. Vol
425,057
52-wk High
1,643.80
52-wk Low
1,006.00

Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company's purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways. The Company is engaged in data sharing and ecommerce in the life sciences. The Company focuses on helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. Two-thirds of the world's 750,000 life science researchers use its affinity binders, reagents, biomarkers and assays and the Company's products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences. It has approximately 10 locations located in the world, through life science research hubs, enabling local services and multi-language support.

Company Address

Abcam PLC

Clifford Allbutt Building
Cambridge Biomedical Campus, Hil
CAMBRIDGE     CB2 0AH
P: +441223.696000
F: +441223.215215

Company Web Links